mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.007 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.01 |